Stockholders Deficit

9 Months Ended

Sep. 30, 2011

Stockholders Deficit [Abstract]

Stockholders Deficit

11. Stockholders Deficit

On July 6, 2011, we completed the July 2011 Financing, which included the sale of 4,300,438 shares of common stock and 3,010,306 warrants to purchase shares of common stock to certain institutional investors for gross proceeds of $3,749,982 and the sale of 4,300,438 shares of common stock and 3,010,306 warrants to purchase shares of common stock to MHR for gross proceeds of $3,749,982. Proceeds from the offering, net of cash issuance costs of $0.3 million, were $7.2 million. Additional issuance costs consisted of $0.6 million from the issuance of the July 2011 MHR Waiver Warrants, as described in Note 10 above, and $25,000 in accrued expenses to reimburse MHR for its legal fees, each in consideration of waiving certain anti-dilution adjustments rights under the MHR Convertible Notes and certain warrants issued by the Company to MHR that would otherwise have been triggered by the July 2011 Financing.